share_log

アクセルM---急騰、親会社が感染症診断技術の開発に向けて60万ドルの研究助成金を獲得

Axcel M--- surged, as the parent company secured a research grant of 0.6 million dollars towards the development of infectious disease diagnostic technology.

Fisco Japan ·  Nov 20 19:30

skyrocketing. Parent company Ascella Biosystems Inc. has received a research grant of 0.6 million dollars from the RADx program of the US National Institutes of Health for the development of infectious disease diagnosis technology. This funding will be an important support for the development of an innovative diagnostic technology “AscellaOne,” which quickly detects multiple respiratory pathogens such as COVID-19. “AscellaOne” is portable yet enables extremely accurate and high-speed diagnosis, early detection of infectious diseases, and rapid treatment, and is particularly designed for use at test sites and at home during the pandemic.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment